Cardea Imaging Center
358 Broadway 2R
Cambridge, MA 02130
Telephone: 877-392-7763

Marcus Welby, MD.
358 Broadway
Cambridge, MA 02139

Donna Flaff
358 Broadway
Cambridge, MA 02139




Bone Density Study
Patient Name: Donna Flaff Sex: Female Ref Physician: Dr. Marcus Welby, MD.
Date of Birth: 06/13/1958 Weight/Height: 113 lbs/63 in Report Date: 01/15/2014
Date of Study: 12/31/13 Ethnicity: Caucasian Hologic Serial#: 45785
History and Osteoporosis Risk Factors
This patient is a 55 year old postmenopausal woman who has experienced no known fragility fractures since age 45. According to a standardized questionnaire, this patient reports the following risk factors for osteoporosis and/or fractures: no vitamin D supplementation, low calcium intake, post-menopausal status and body weight less than 127 lbs.
Current and Past Treatment
This patient reports no current intake of medications or supplements known to benefit skeletal health. No past treatments for osteoporosis were reported.
Results
Anatomical Region T-score 1 Z-score 2
PA Spine (L1, L2, L3, L4) -2.0 -0.9
Left Hip (Neck) -1.6 -0.5
The technical quality of the spine image has been designated good.The technical quality of the left hip image has been designated good.
1Based on internationally accepted standards, the T-scores are now calculated by comparing the patient’s bone density(BMD) to a database of normal, white adults (age 25-30) of the same gender. Results are reported as standard deviations from the mean BMD. 2Z-scores compare the patient's BMD to his or her age-matched peers of the same ethnicity if a sufficiently large ethnic database is available,( ie if ethnicity is white, black, or Hispanic). For other ethnic groups, a white, age-matched database is used for comparison.
Diagnosis
According to diagnostic criteria established by the World Health Organization, these results indicate Low Bone Mass (osteopenia) in at least one skeletal site.

Comparison to Prior Studies
Bone density decreased significantly by 8.0% in the total PA spine between 12/20/2011 and 12/31/2013. The bone density in the total left hip was stable between 12/20/2011 and 12/31/2013.
Confidentiality/Disclosure Warning: This transmittal contains privileged and confidential information intended for use by a physician. Use, copying, or distributing by any other person is strictly prohibited. If you have received this transmittal in error, please notify us by telephone at 973-322-7430 and return the misdirected transmittal to us by U.S. mail (See address at top of document).
Page 1
 

Patient: Donna Flaff MRN: 157419 Date of Birth: 06/13/1958 Acc #: .9364417

Impression and Recommendations
Based on gender, current age, hip bone density, BMI and ethnicity, this patient's 10 year risk for major osteoporotic fractures is 5.9%. The 10 year risk for hip fracture is 0.5%. The level of fracture risk does not meet current NOF guidelines for pharmacologic therapy.

This calculation of 10-year fracture risk using the WHO FRAX(R) (v3.6) algorithm is based on information provided by the patient per questionnaire. Other clinical information which could affect fracture risk and/or the benefit:risk ratio of therapy should also be considered in making therapeutic decisions.

The National Osteoporosis Foundation recommends considering pharmacologic intervention for postmenopausal women with osteopenia if the 10-year probability of major osteoporotic fractures is 20% or more or if the risk of hip fracture is 3% or greater.

To reduce further bone loss and the risk for future fractures, she should follow a healthy lifestyle consisting of good nutrition with adequate calcium and vitamin D intake as well as regular weight-bearing exercise.

Consider repeat bone density testing in 2-3 years.For monitoring, follow-up bone density testing must be performed on the same machine. Otherwise, it may be impossible to tell whether changes in bone density are due to machine variations or to a true change in the patient.



Reviewed By: Administrator Signature: _____________________________________________

Confidentiality/Disclosure Warning: This transmittal contains privileged and confidential information intended for use by a physician. Use, copying, or distributing by any other person is strictly prohibited. If you have received this transmittal in error, please notify us by telephone at 877-392-7763 and return the misdirected transmittal to us by U.S. mail (See address at top of document).
Page 2
 

Patient: Donna Flaff MRN: 157419 Date of Birth: 06/13/1958 Acc #: .9364417

Current Studies

PA Spine



DXA Results: PA Spine Summary
Region Area cm2 BMC g BMD g/cm2 T-score
L1 11.62 9.18 0.79 -1.8
L2 12.86 10.88 0.846 -1.7
L3 13.64 11.16 0.818 -2.4
L4 16.01 13.4 0.837 -2.0
Total 54.12 44.62 0.824 -2.0
Serial Results: PA Spine (L1, L2, L3, L4)
. BMD g/cm2 Change Since
Scan Date BMD g/cm2 Baseline Previous
12/31/13 0.824 -0.072 (-8%) -0.011 (-1%)
12/03/12 0.835 -0.061 (-7%) -0.061 (-7%)
12/20/11 0.896 N/A N/A



Left Hip



DXA Results: Left Hip Summary
Region Area cm2 BMC g BMD g/cm2 T-score
Neck 5.08 3.43 0.675 -1.6
Trochanter 10.9 6.51 0.597 -1.0
Total 32.73 25.74 0.786 -1.3
Serial Results: Left Hip (Total)
. BMD g/cm2 Change Since
Scan Date BMD g/cm2 Baseline Previous
12/31/13 0.786 -0.045 (-5%) -0.001 (-0%)
12/03/12 0.787 -0.044 (-5%) -0.044 (-5%)
12/20/11 0.831 N/A N/A



Confidentiality/Disclosure Warning: This transmittal contains privileged and confidential information intended for use by a physician. Use, copying, or distributing by any other person is strictly prohibited. If you have received this transmittal in error, please notify us by telephone at 877-392-7763 and return the misdirected transmittal to us by U.S. mail (See address at top of document).
Page 3